Helicos has a new CEO
Helicos BioSciences Corp., a Cambridge company focused on gene-sequencing instruments, said that its board of directors has appointed Ivan Trifunovich as the company's president and chief executive.
"Dr. Trifunovich has served as a senior consultant to the Helicos board of directors and was elected to serve as executive chairman of the board of Helicos on Sept. 15, 2010," the company said in a press release. "Ron Lowy, who stepped in as CEO at the board's request, will return to his role as a board member."
Trifunovich has served as a consultant to companies in the life sciences industry, and his resume includes as stint as senior vice president of Third Wave Technologies, Inc., a molecular diagnostics company.
In a statement, Trifunovich said: "Helicos was the first to invent and market single molecule sequencing technology and has established a comprehensive patent estate with the earliest priority dates in the field. We are pleased to announce that our foundational patents will be made available to encourage broad commercialization of genetic sequencing-by-synthesis and other related technologies."